Bourdon David 4

What Happened

• David Bourdon, CEO of LifeStance Health Group (LFST), was granted 395,683 restricted stock units (RSUs) on March 5, 2026 (reported as an acquisition at $0). On March 6, 2026, 65,837 shares were withheld by the company to satisfy tax withholding related to the net settlement of RSUs that vested, a withholding valued at $456,250 (at $6.93 per share). The withheld shares were not sold on the open market.

Key Details

• Transaction dates: RSU grant March 5, 2026; tax withholding/net settlement March 6, 2026.
• Grant: 395,683 RSUs (each RSU converts to one share upon settlement). Reported acquisition price: $0 (typical for RSU grants).
• Withheld: 65,837 shares withheld to satisfy tax liability at $6.93/share, totaling $456,250 (reported as disposition code F).
• Net shares issued to Bourdon upon settlement (395,683 − 65,837): 329,846 shares.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnotes: F1 confirms the award was RSUs (one RSU = one contingent share). F2 clarifies the withheld shares were to satisfy tax withholding on net-settled vested RSUs and do not represent an open-market sale.
• Filing: Form 4 filed March 9, 2026; appears timely for these transactions.

Context

• This is a grant/settlement of RSUs with standard tax-withholding using company shares (a net-settlement), not an active market sale. Such transactions reflect compensation/vesting rather than a buy or sell decision by the insider.